Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Amneal Pharmaceuticals Inc Class A stock

Learn how to easily invest in Amneal Pharmaceuticals Inc Class A stock.

Amneal Pharmaceuticals Inc Class A is a drug manufacturers-specialty & generic business based in the US. Amneal Pharmaceuticals Inc Class A shares (AMRX) are listed on the NYSE and all prices are listed in US Dollars. Amneal Pharmaceuticals Inc Class A employs 7,000 staff and has a trailing 12-month revenue of around $2.1 billion.

How to buy Amneal Pharmaceuticals Inc Class A stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – AMRX. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Best for low fees

Finder Award

SoFi Invest


  • Trade stocks for $0 and no annual fee
  • Start trading with a $0 minimum deposit
  • Get up to $1,000 when you fund a new account within 30 days

Best for beginners

Finder Award

eToro


  • Easy to use platform with low fees
  • Social trading allows you to copy popular portfolios
  • FINDER EXCLUSIVE: Get $15 when you sign up and deposit $100

Promoted for easy user experience

Robinhood


  • Get free stock upon signup
  • Earn 4% interest on uninvested cash with Robinhood Gold
  • Get 1% match on contributions to a Robinhood IRA

Amneal Pharmaceuticals Inc Class A stock price (NYSE: AMRX)

Use our graph to track the performance of AMRX stocks over time.

Amneal Pharmaceuticals Inc Class A shares at a glance

Information last updated 2023-02-02.
Latest market close$2.43
52-week range$1.95 - $4.98
50-day moving average $2.24
200-day moving average $2.75
Wall St. target price$5.42
PE ratio 234
Dividend yield $0 (0%)
Earnings per share (TTM) $0.01

Buy Amneal Pharmaceuticals Inc Class A stocks from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 6 of 6
Name Product Available asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get up to $1,000
when you fund a new account within 30 days.
Winner of Finder’s Best Low-Cost Broker award.
Finder Award
eToro
Stocks, Options, ETFs, Cryptocurrency
$0
$10
FINDER EXCLUSIVE: Get $15
when you sign up and deposit $100
Winner of Finder’s Best Broker for Beginners award. Not available in NY, NV, MN, TN, and HI.
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 4% interest on uninvested cash in your account with Robinhood Gold.
tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
Get $200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Highly commended for Best Derivatives Trading Platform award.
Public.com
Stocks, ETFs, Cryptocurrency, Alternatives
$0
$0
Get up to $300 in either stocks or crypto
when you use code FINDERUS to sign up and fund a new account.
Trade stocks and ETFs commission-free, plus gain access to alternative investments like art, NFTs and more.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex
$0
$0
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Compare up to 4 providers

Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.

Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.

Is it a good time to buy Amneal Pharmaceuticals Inc Class A stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Amneal Pharmaceuticals Inc Class A price performance over time

Historical closes compared with the close of $2.43 from 2023-02-03

1 week (2023-01-31) 10.45%
1 month (2023-01-06) 9.95%
3 months (2022-11-07) 3.40%
6 months (2022-08-05) -23.58%
1 year (2022-02-07) -47.85%
2 years (2021-02-05) -53.27%
3 years (2020-02-07) 4.85
5 years (2018-02-07) 20

Is Amneal Pharmaceuticals Inc Class A stock undervalued or overvalued?

Valuing Amneal Pharmaceuticals Inc Class A stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Amneal Pharmaceuticals Inc Class A's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Amneal Pharmaceuticals Inc Class A's P/E ratio

Amneal Pharmaceuticals Inc Class A's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 234x. In other words, Amneal Pharmaceuticals Inc Class A shares trade at around 234x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

Amneal Pharmaceuticals Inc Class A's EBITDA

Amneal Pharmaceuticals Inc Class A's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $401.8 million.

The EBITDA is a measure of a Amneal Pharmaceuticals Inc Class A's overall financial performance and is widely used to measure a its profitability.

Amneal Pharmaceuticals Inc Class A financials

Revenue TTM $2.1 billion
Operating margin TTM 7.55%
Gross profit TTM $783.9 million
Return on assets TTM 2.57%
Return on equity TTM -87.59%
Profit margin -6.17%
Book value $1.96
Market capitalisation $710.4 million

TTM: trailing 12 months

Amneal Pharmaceuticals Inc Class A share dividends

We're not expecting Amneal Pharmaceuticals Inc Class A to pay a dividend over the next 12 months.

Amneal Pharmaceuticals Inc Class A share price volatility

Over the last 12 months, Amneal Pharmaceuticals Inc Class A's shares have ranged in value from as little as $1.95 up to $4.98. A popular way to gauge a stock's volatility is its "beta".

AMRX.US volatility(beta: 1.35)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Amneal Pharmaceuticals Inc Class A's is 1.3525. This would suggest that Amneal Pharmaceuticals Inc Class A's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Amneal Pharmaceuticals Inc Class A overview

Amneal Pharmaceuticals, Inc. , together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and commercializes complex oral solids, injectables, ophthalmics, liquids, topicals, softgels, inhalation products, and transdermals across a range of therapeutic categories. The Specialty segment is involved in the development, promotion, distribution, and sale of branded pharmaceutical products with focus on central nervous system disorders, endocrinology, parasitic infections, and other therapeutic areas. It also offers Emverm, a chewable tablet for the treatment of pinworm, whipworm, common roundworm, common hookworm, and American hookworm in single or mixed infections; Rytary to treat Parkinson's disease; and Unithroid for the treatment of hypothyroidism. The AvKARE segment provides pharmaceuticals, medical and surgical products, and services primarily to governmental agencies, the Department of Defense, and the Department of Veterans Affairs.

Frequently asked questions

What percentage of Amneal Pharmaceuticals Inc Class A is owned by insiders or institutions?
Currently 10.81% of Amneal Pharmaceuticals Inc Class A shares are held by insiders and 64.729% by institutions.
How many people work for Amneal Pharmaceuticals Inc Class A?
Latest data suggests 7,000 work at Amneal Pharmaceuticals Inc Class A.
When does the fiscal year end for Amneal Pharmaceuticals Inc Class A?
Amneal Pharmaceuticals Inc Class A's fiscal year ends in December.
Where is Amneal Pharmaceuticals Inc Class A based?
Amneal Pharmaceuticals Inc Class A's address is: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
What is Amneal Pharmaceuticals Inc Class A's ISIN number?
Amneal Pharmaceuticals Inc Class A's international securities identification number is: US03168L1052
What is Amneal Pharmaceuticals Inc Class A's CUSIP number?
Amneal Pharmaceuticals Inc Class A's Committee on Uniform Securities Identification Procedures number is: 03168L105

More guides on Finder

Ask an Expert

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site